Get the Stockscreener App
6.84
2.25%
0.18
Electrocore Inc stock is traded at $6.84, with a volume of 46,727.
It is up +2.25% in the last 24 hours and up +49.67% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$6.66
Open:
$6.66
24h Volume:
46,727
Relative Volume:
0.69
Market Cap:
$53.09M
Revenue:
$27.70M
Net Income/Loss:
$-13.25M
P/E Ratio:
-4.2222
EPS:
-1.62
Net Cash Flow:
$-7.66M
1W Performance:
-16.44%
1M Performance:
+49.67%
6M Performance:
+0.59%
1Y Performance:
-59.27%
1-Day Range:
$6.64
$7.11
1-Week Range:
$6.55
$8.30
52-Week Range:
$4.16
$19.49
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
6.64 | 53.25M | 27.70M | -13.25M | -7.66M | -1.62 |
|
ABT
Abbott Laboratories
|
110.12 | 190.06B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
369.44 | 141.33B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
BSX
Boston Scientific Corp
|
93.23 | 138.71B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
103.11 | 132.00B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
82.84 | 47.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
Setup Watch: Is electroCore Inc being accumulated by smart moneyJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
electroCore (NASDAQ:ECOR) Stock Rating Lowered by Zacks Research - MarketBeat
What’s the RSI of electroCore Inc. stockLayoff News & Low Drawdown Trading Strategies - mfd.ru
Analysts Set Expectations for electroCore FY2025 Earnings - Defense World
electroCore FY2025 EPS Forecast Increased by HC Wainwright - MarketBeat
HC Wainwright Comments on electroCore FY2030 Earnings - Defense World
HC Wainwright Estimates electroCore FY2030 Earnings - MarketBeat
electroCore (NASDAQ:ECOR) Given New $18.00 Price Target at HC Wainwright - Defense World
H.C. Wainwright lowers electroCore stock price target to $18 on higher expenses By Investing.com - Investing.com South Africa
H.C. Wainwright lowers electroCore stock price target to $18 on higher expenses - Investing.com Nigeria
HC Wainwright Has Lowered Expectations for electroCore (NASDAQ:ECOR) Stock Price - MarketBeat
electroCore's (ECOR) Price Target Lowered by HC Wainwright & Co. | ECOR Stock News - GuruFocus
Digital Migraine Treatment Devices Market to Reach USD 298.71 - openPR.com
electroCore (ECOR) Partners with Acacia Clinics for PTSD Treatme - GuruFocus
Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder ('PTSD”) - manilatimes.net
Acacia Clinics and Vagus Nerve Society Conduct Study Using - GlobeNewswire
ElectroCore Announces Record Preliminary 2025 Revenue Guidance - TipRanks
electroCore reports 26% revenue growth for 2025 By Investing.com - Investing.com Canada
ECOR Ends 2025 with Lower Cash Reserves - GuruFocus
electroCore reports 26% revenue growth for 2025 - Investing.com
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8-$32.0 Million - The Manila Times
ElectroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million - marketscreener.com
electroCore Provides Preliminary Full-Year 2025 Business - GlobeNewswire
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million - Sahm
Financial Survey: Telomir Pharmaceuticals (NASDAQ:TELO) versus electroCore (NASDAQ:ECOR) - Defense World
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - Intellectia AI
EPS Watch: Is electroCore Inc stock cheap at current valuationJuly 2025 Update & Daily Volume Surge Trade Alerts - Bộ Nội Vụ
Will electroCore Inc. stock outperform international peersTrend Reversal & Fast Moving Trade Plans - ulpravda.ru
Market Rankings: Will electroCore Inc stock keep outperforming rivalsEarnings Miss & High Conviction Buy Zone Picks - moha.gov.vn
Short Covering: How geopolitical risks impact electroCore Inc. (43E0) stockPortfolio Value Summary & Fast Momentum Entry Tips - ulpravda.ru
electroCore, Inc.'s (NASDAQ:ECOR) Price Is Right But Growth Is Lacking - simplywall.st
Can electroCore Inc. stock maintain growth trajectoryJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - Улправда
Will electroCore Inc. stock outperform Dow Jones indexJuly 2025 Final Week & Consistent Growth Equity Picks - Улправда
How geopolitical risks impact electroCore Inc. (43E0) stockShort Setup & Verified Trade Idea Suggestions - Улправда
Will electroCore Inc. stock split attract more investorsWeekly Volume Report & High Conviction Investment Ideas - Улправда
Market Review: Can electroCore Inc. stock maintain growth trajectoryPrice Action & Smart Allocation Stock Reports - Улправда
Will electroCore Inc. stock outperform value stocks2026 world cup usa national team round of 32 young talents high defensive line odds analysis analysis - ulpravda.ru
Market Overview: Will electroCore Inc 43E0 stock announce special dividend2025 Risk Factors & Weekly Stock Breakout Alerts - Bộ Nội Vụ
electroCore (NASDAQ:ECOR) Trading Up 1.4% – What’s Next? - Defense World
Vagus Nerve Stimulators Market Industry Analysis 2025-2032 - openPR.com
ECOR SEC FilingsElectrocore 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Expect Breakeven For electroCore, Inc. (NASDAQ:ECOR) Before Long - Yahoo Finance
FOMO Trade: Will electroCore Inc. stock outperform international peersJuly 2025 Volume & Verified Technical Signals - Улправда
Will electroCore Inc. stock outperform tech sector in 20252025 Market Trends & Free Expert Verified Stock Movement Alerts - Улправда
Why electroCore Inc. stock remains a top recommendationTrade Risk Assessment & Free Low Drawdown Momentum Trade Ideas - DonanımHaber
Is electroCore Inc. stock safe for conservative investors2025 Trade Ideas & Daily Chart Pattern Signal Reports - DonanımHaber
Will electroCore Inc. stock deliver consistent dividends2025 Earnings Impact & Safe Investment Capital Preservation Plans - Улправда
electroCore Earnings Notes - Trefis
How analysts rate electroCore Inc stock todayJuly 2025 Drop Watch & Consistent Return Strategy Ideas - moha.gov.vn
electroCore plummets 50% after InvestingPro’s overvalued warning By Investing.com - Investing.com India
United States Digital Migraine Treatment Devices Market - openPR.com
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Electrocore Inc Stock (ECOR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Goldberger Daniel S | Chief Executive Officer |
Dec 02 '25 |
Buy |
4.84 |
1,000 |
4,840 |
292,565 |
| Lev Joshua S. | Chief Financial Officer |
Nov 12 '25 |
Sale |
6.18 |
2,166 |
13,386 |
23,667 |
| Errico Thomas J. | Director |
Aug 11 '25 |
Buy |
4.47 |
15,000 |
67,050 |
281,401 |
| Goldberger Daniel S | Chief Executive Officer |
Aug 11 '25 |
Buy |
4.23 |
1,000 |
4,230 |
291,565 |
| GANDOLFO JOHN P | Director |
May 23 '25 |
Buy |
5.01 |
1,800 |
9,018 |
69,087 |
| Errico Thomas J. | Director |
May 12 '25 |
Buy |
4.77 |
10,000 |
47,735 |
266,401 |
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):